CL2013002370A1 - Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionados - Google Patents
Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionadosInfo
- Publication number
- CL2013002370A1 CL2013002370A1 CL2013002370A CL2013002370A CL2013002370A1 CL 2013002370 A1 CL2013002370 A1 CL 2013002370A1 CL 2013002370 A CL2013002370 A CL 2013002370A CL 2013002370 A CL2013002370 A CL 2013002370A CL 2013002370 A1 CL2013002370 A1 CL 2013002370A1
- Authority
- CL
- Chile
- Prior art keywords
- texasporus
- inactivation
- procedures
- cells
- efficient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161447703P | 2011-03-01 | 2011-03-01 | |
| US13/406,202 US8673290B2 (en) | 2011-03-01 | 2012-02-27 | Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002370A1 true CL2013002370A1 (es) | 2014-04-04 |
Family
ID=46753436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002370A CL2013002370A1 (es) | 2011-03-01 | 2013-08-16 | Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionados |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8673290B2 (es) |
| EP (2) | EP3002340A1 (es) |
| JP (1) | JP5970483B2 (es) |
| KR (1) | KR20140015356A (es) |
| CN (2) | CN105567587A (es) |
| AR (1) | AR088715A1 (es) |
| AU (1) | AU2012223481B2 (es) |
| BR (1) | BR112013021892B1 (es) |
| CA (1) | CA2828541C (es) |
| CL (1) | CL2013002370A1 (es) |
| CO (1) | CO6751281A2 (es) |
| MX (1) | MX350277B (es) |
| RU (1) | RU2013137673A (es) |
| WO (1) | WO2012118845A1 (es) |
| ZA (1) | ZA201306276B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014099829A1 (en) * | 2012-12-17 | 2014-06-26 | MYGALAXY Limited Company | Uses of bt lipopeptides as therapeutics for obesity and related diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4302544A (en) | 1979-10-15 | 1981-11-24 | University Of Rochester | Asporogenous mutant of B. subtilis for use as host component of HV1 system |
| US4465773A (en) | 1982-04-21 | 1984-08-14 | Cpc International Inc. | Amylase-negative, asporogenous mutant of Bacillus subtilis useful as a host in a host-vector system |
| US4450236A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of Bacillus subtilis useful as a host in a host-vector system |
| US4450235A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system |
| US5480641A (en) | 1990-06-15 | 1996-01-02 | Biogaia Ab | Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract |
| IT1244477B (it) | 1990-12-21 | 1994-07-15 | Eniricerche Spa | Ceppo asporigeno di bacillus subtilis e suo impiego come ospite per la preparazione di prodotti eterologhi |
| CA2523711A1 (en) | 2003-04-28 | 2004-11-11 | Alpharma, Inc. | Method for formulation of microbial feed additives with feed |
| WO2005045005A1 (ja) * | 2003-11-11 | 2005-05-19 | Higeta Shoyu Co., Ltd. | 新規ブレビバチルス・チョウシネンシス及び該微生物を宿主とするタンパク質の製造方法 |
| BRPI0507186A (pt) * | 2004-01-30 | 2007-06-26 | Texas A & M Univ Sys | composição, métodos e usos para uma nova famìlia de peptìdeos |
| JP2010220539A (ja) * | 2009-03-24 | 2010-10-07 | Tosoh Corp | 胞子形成能が欠損した細菌、及びそれを用いたタンパク質製造方法 |
-
2012
- 2012-02-27 US US13/406,202 patent/US8673290B2/en active Active
- 2012-02-28 RU RU2013137673/10A patent/RU2013137673A/ru not_active Application Discontinuation
- 2012-02-28 CN CN201510993878.4A patent/CN105567587A/zh active Pending
- 2012-02-28 CN CN201280020898.8A patent/CN103732734B/zh active Active
- 2012-02-28 MX MX2013009993A patent/MX350277B/es active IP Right Grant
- 2012-02-28 WO PCT/US2012/026999 patent/WO2012118845A1/en active Application Filing
- 2012-02-28 JP JP2013556816A patent/JP5970483B2/ja not_active Expired - Fee Related
- 2012-02-28 KR KR1020137023142A patent/KR20140015356A/ko not_active Application Discontinuation
- 2012-02-28 AU AU2012223481A patent/AU2012223481B2/en not_active Ceased
- 2012-02-28 EP EP15196151.3A patent/EP3002340A1/en not_active Withdrawn
- 2012-02-28 BR BR112013021892-4A patent/BR112013021892B1/pt not_active IP Right Cessation
- 2012-02-28 EP EP12712165.5A patent/EP2681338B1/en not_active Not-in-force
- 2012-02-28 CA CA2828541A patent/CA2828541C/en not_active Expired - Fee Related
- 2012-03-01 AR ARP120100673A patent/AR088715A1/es unknown
-
2013
- 2013-08-16 CL CL2013002370A patent/CL2013002370A1/es unknown
- 2013-08-20 ZA ZA2013/06276A patent/ZA201306276B/en unknown
- 2013-08-28 CO CO13204350A patent/CO6751281A2/es unknown
-
2014
- 2014-02-13 US US14/179,926 patent/US20140162343A1/en not_active Abandoned
- 2014-02-13 US US14/179,933 patent/US20140199753A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013009993A (es) | 2013-12-06 |
| AU2012223481A1 (en) | 2013-08-29 |
| CN103732734A (zh) | 2014-04-16 |
| US8673290B2 (en) | 2014-03-18 |
| CO6751281A2 (es) | 2013-09-16 |
| MX350277B (es) | 2017-08-30 |
| CA2828541C (en) | 2020-04-21 |
| US20120225037A1 (en) | 2012-09-06 |
| EP2681338A1 (en) | 2014-01-08 |
| US20140162343A1 (en) | 2014-06-12 |
| EP2681338B1 (en) | 2015-11-25 |
| BR112013021892A2 (pt) | 2016-09-06 |
| ZA201306276B (en) | 2016-07-27 |
| CN103732734B (zh) | 2016-01-20 |
| AR088715A1 (es) | 2014-07-02 |
| US20140199753A1 (en) | 2014-07-17 |
| EP3002340A1 (en) | 2016-04-06 |
| CA2828541A1 (en) | 2012-09-07 |
| BR112013021892B1 (pt) | 2021-01-05 |
| KR20140015356A (ko) | 2014-02-06 |
| RU2013137673A (ru) | 2015-04-10 |
| WO2012118845A1 (en) | 2012-09-07 |
| CN105567587A (zh) | 2016-05-11 |
| AU2012223481B2 (en) | 2016-06-30 |
| JP2014512807A (ja) | 2014-05-29 |
| JP5970483B2 (ja) | 2016-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2505123B (en) | Social media identity discovery and mapping | |
| CL2015001666A1 (es) | Preparación de éteres de poli-alfa-1,3-glucano | |
| DK2726145T3 (da) | Minimalt invasivt, dermalt elektroporationsapparat | |
| EP2748781A4 (en) | TWO FACTOR IDENTITY FINGER PRINTING PROCEDURES WITH USER BEHAVIOR | |
| BR112015002868A2 (pt) | dispositivos, sistemas e métodos para se engajar tecido | |
| BR112015006198A2 (pt) | conjunto de cadeira | |
| DK2837680T3 (da) | Mammaliacellekultur | |
| DK3432649T3 (da) | Radionetværksknude, brugerindretning og fremgangsmåder dertil | |
| DK2882850T3 (da) | System for preparation of adipose-derived stem cells | |
| CO6960510A2 (es) | Celdas fotocatalíticas mejoradas | |
| BR112014027730A2 (pt) | material, e material não tecido | |
| DK2861711T3 (da) | Engangsbioreaktor og hovedplade, og en fremgangsmåde til fremstilling deraf | |
| GB2512003B (en) | Physical mapping of wireless networks | |
| EP2659332A4 (en) | Wireless ad-hoc network facilitating social interactions among plurality of users | |
| FR2994831B1 (fr) | Prothese de main. | |
| DK2772001T3 (da) | Dynamisk krypteringsfremgangsmåde | |
| FI20126195A (fi) | Menetelmä, järjestely ja hissijärjestelmä | |
| BR112014026557A2 (pt) | fralda descartável. | |
| BR112014020372A8 (pt) | n-etil-n-fenil-1,2-di-hidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, preparação e utilização do mesmo | |
| DK2914574T3 (da) | Ny fremgangsmåde | |
| DK2888100T3 (da) | Fremstillingsfremgangsmåde, fremstillingsform og anvendelse | |
| GB2507970B (en) | Self-configuration of wireless networks | |
| BR112014010432A2 (pt) | uso médico | |
| CL2013002370A1 (es) | Celulas de b. texasporus de esporulacion deficiente y procedimientos para la inactivacion eficiente y de bajo costo y usuos relacionados | |
| DK2446780T3 (da) | Stol, især kontorstol |